Well, sadly, the approval comes too late for this allergy season... Won't help $INNV a bit... Likely to be next year before the company begins selling any $AKRX product....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.